The Saskatchewan and federal governments have announced an agreement for coverage of select new drugs for rare diseases.
Ottawa says the plan is to invest more than $40 million to cover three drugs that treat certain cancers and a urinary issue.
Get weekly health news
Receive the latest medical news and health information delivered to you every Sunday.
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.
The medicines are Poteligeo, Oxlumo and Epkinly.
The agreement is to also see Saskatchewan work with Ottawa and other provinces to develop a plan to improve screening and diagnostics for rare diseases.
Federal Health Minister Mark Holland says the deal helps the health system improve outcomes for those in Saskatchewan with rare diseases.
Comments